Details for New Drug Application (NDA): 202897
✉ Email this page to a colleague
The generic ingredient in ACITRETIN is acitretin. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acitretin profile page.
Summary for 202897
Tradename: | ACITRETIN |
Applicant: | Teva Pharms Usa |
Ingredient: | acitretin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 202897
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACITRETIN | acitretin | CAPSULE;ORAL | 202897 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-1138 | 0093-1138-56 | 30 CAPSULE in 1 BOTTLE (0093-1138-56) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 17.5MG | ||||
Approval Date: | Apr 4, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 22.5MG | ||||
Approval Date: | Apr 4, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription